Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes
暂无分享,去创建一个
T. Matsuo | A. Becker | M. Yoshiyama | H. Itabe | T. Takano | J. Yoshikawa | M. Otsuka | S. Ehara | R. Komatsu | T. Naruko | M. Ueda | A. Itoh | K. Haze | K. Takeuchi | Y. Tsukamoto
[1] F. Werf,et al. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. , 1998, Circulation.
[2] K. Koch,et al. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes , 1998, Heart.
[3] D. Collen,et al. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[4] Wei Sha,et al. Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo * , 1997, The Journal of Biological Chemistry.
[5] S. Thompson,et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.
[6] M. Eldar,et al. Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. , 1996, Heart.
[7] Y. Hata,et al. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. , 1996, Journal of lipid research.
[8] D. Collen,et al. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. , 1995, The Journal of clinical investigation.
[9] D. Collen,et al. Oxidized lipoproteins in atherosclerosis and thrombosis , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] V. Fuster,et al. Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture , 1994, Circulation.
[11] E. Anggard,et al. Oxidative modification of low-density lipoprotein by human polymorphonuclear leucocytes to a form recognised by the lipoprotein scavenger pathway. , 1994, Biochimica et biophysica acta.
[12] Y. Yoshida,et al. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides. , 1994, The Journal of biological chemistry.
[13] A. Becker,et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.
[14] The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) , 1993, Archives of internal medicine.
[15] D. Leake,et al. The oxidative modification of low density lipoprotein by human lymphocytes. , 1992, Atherosclerosis.
[16] E. Braunwald,et al. Unstable angina. A classification. , 1989, Circulation.
[17] J L Witztum,et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.
[18] D. Steinberg,et al. Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor , 1986, Arteriosclerosis.